Underground railway particulate matter and susceptibility to pneumococcal infection.
London underground
Particulate matter
Pneumococcal infection
Journal
EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
26
01
2022
revised:
26
04
2022
accepted:
30
04
2022
pubmed:
23
5
2022
medline:
15
6
2022
entrez:
22
5
2022
Statut:
ppublish
Résumé
Concentrations of particulate matter less than 10 microns (PM A549 cells and human primary airway epithelial cells were cultured with 20 µg/mL PM In A549 cells, human primary nasal cells, and human primary bronchial epithelial cells, B-PM LU-PM The Medical College of Saint Bartholomew's Hospital Trust, and the UK Medical Research Council Programme Grant (MR/P011284/1).
Sections du résumé
BACKGROUND
BACKGROUND
Concentrations of particulate matter less than 10 microns (PM
METHODS
METHODS
A549 cells and human primary airway epithelial cells were cultured with 20 µg/mL PM
FINDINGS
RESULTS
In A549 cells, human primary nasal cells, and human primary bronchial epithelial cells, B-PM
INTERPRETATION
CONCLUSIONS
LU-PM
FUNDING
BACKGROUND
The Medical College of Saint Bartholomew's Hospital Trust, and the UK Medical Research Council Programme Grant (MR/P011284/1).
Identifiants
pubmed: 35598440
pii: S2352-3964(22)00244-4
doi: 10.1016/j.ebiom.2022.104063
pmc: PMC9127572
pii:
doi:
Substances chimiques
Particulate Matter
0
Cysteine
K848JZ4886
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104063Subventions
Organisme : Medical Research Council
ID : MR/P011284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R002592/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Références
J Allergy Clin Immunol. 2011 May;127(5):1236-42.e2
pubmed: 21247619
J Allergy Clin Immunol. 2020 Apr;145(4):1272-1284.e6
pubmed: 31983527
Eur J Pharmacol. 1986 Apr 9;123(1):91-7
pubmed: 3709663
Occup Environ Med. 2005 Jun;62(6):355-62
pubmed: 15901881
Thorax. 2014 Nov;69(11):1027-33
pubmed: 25164925
Cell Microbiol. 2020 Feb;22(2):e13141
pubmed: 31709673
Environ Health Perspect. 2014 Jan;122(1):107-13
pubmed: 24149084
Nature. 1995 Oct 5;377(6548):435-8
pubmed: 7566121
J Environ Monit. 2010 Oct 6;12(10):1807-14
pubmed: 20676427
Infect Immun. 2000 Feb;68(2):492-501
pubmed: 10639409
Immunobiology. 2010 Apr;215(4):251-63
pubmed: 20071053
Chem Res Toxicol. 2008 Mar;21(3):726-31
pubmed: 18260651
Am J Respir Crit Care Med. 2014 May 15;189(10):1250-9
pubmed: 24749506
J Allergy Clin Immunol. 2017 Mar;139(3):977-986.e2
pubmed: 27523432
Thorax. 2012 Oct;67(10):908-13
pubmed: 22550083
Sci Total Environ. 2015 Apr 1;511:711-22
pubmed: 25616190
Environ Int. 2020 Jan;134:105188
pubmed: 31787325
Environ Health Perspect. 2021 Feb;129(2):27001
pubmed: 33565894
Int J Chron Obstruct Pulmon Dis. 2016 Jul 25;11:1647-55
pubmed: 27524890
J Allergy Clin Immunol. 2016 Feb;137(2):527-534.e7
pubmed: 26277596
BMJ. 2021 Sep 23;374:n2349
pubmed: 34556465
Part Fibre Toxicol. 2019 Mar 6;16(1):12
pubmed: 30841934